PL EN


Preferences help
enabled [disable] Abstract
Number of results
2007 | 79 | 8 | 526-532
Article title

Results of Serum Lipid Concentration Measurements Associated with the Level of Arteriosclerosis in Patients with Advanced Lower Extremity Ischaemia

Content
Title variants
Languages of publication
EN
Abstracts
EN
The aim of the study was to evaluate whether serum lipid concentrations [total cholesterol (TC), HDL cholesterol (HDL), LDL cholesterol (LDL), triglycerides (TG)] vary between patients with lower extremity claudication depending on the location of pathologic arterial changes above and below the inguinal ligament.Material and methods. Our investigation included 24 patients with changes in the aorto-iliac and 15 in the femoro-popliteal segment, in whom advanced ischaemia reached IIb and III according to Fontaine's scale. The results obtained from our patients were compared to non-claudicant controls, who were matched to the claudification patients with respect to age, body mass index, smoking and concomitant illnesses.Results. Every fourth patient with claudication demonstrated correct results of the four mentioned lipidogram components. The percentage of incorrect results was higher in patients with changes in the aorto-iliac segment relative to patients with changes in the femoro-popliteal segment and amounted to 63% vs 20% for HDL, and 63% vs 13% for TG, respectively. TG concentration and TC/HDL and LDL/HDL ratios vary between the two groups of patients. TC/HDL and LDL/HDL ratios are significantly higher in patients with aorto-iliac segment changes as compared to the control group, but do not vary when compared to arteries below the inguinal ligament. The level of TC, HDL and LDL is higher in the control group as compared to the median results for all examined patients.Conclusions. Patients with lower limb claudication following pathology of the aorto-iliac and femoropopliteal segments do not constitute a homologous group; therefore, further extensive research is necessary to explain this phenomenon.
Publisher

Year
Volume
79
Issue
8
Pages
526-532
Physical description
Dates
published
1 - 8 - 2007
online
27 - 11 - 2007
Contributors
  • Department of Vascular Diseases, Collegium Medicum Jagiellonian University in Cracow
  • Unit of Clinical Epidemiology and Population Studies, Collegium Medicum Jagiellonian University in Cracow
  • Department of Vascular Diseases, Collegium Medicum Jagiellonian University in Cracow
  • Unit of Clinical Epidemiology and Population Studies, Collegium Medicum Jagiellonian University in Cracow
References
  • Case CC, Ballantyne CM: Statins and inflammatory markers. Curr Atheroscler Rep 2002; 4: 42-47.
  • Francisco G, Hernandez C, Simo R: Serum markers of vascular inflammation in dyslipidemia. Clin Chim Acta 2006; 369: 1-16.
  • Mowat BF, Skinner ER, Wilson HM et al.: Alterations in plasma lipids, lipoproteins and high density lipoprotein subfraction in peripheral arterial disease. Atherosclerosis 1997; 131: 161-66.
  • Durst R, Rund D, Schurr D et al.: One year experience with a low density lipoprotein apheresis system. Isr Med Assoc 2002; 4: 677-80.
  • Hershcovici T, Schechner V, Orlin J et al.: Effect of different LDL apheresis methods on parameters involved in atherosclerosis. J Clin Apher 2004; 19: 90-97.
  • Kobayashi S, Oka M, Moriya H et al.: LDL apheresis reduces P selectin, CRP and fibrinogen - possible important implications for improving atherosclerosis. Ther Apher Dial 2006; 10: 219-23.[PubMed][Crossref]
  • Empen K, Otto C, Brodi UC et al.: The effects of three different LDL apheresis methods on the plasma concentrations of E selectin, VCAM1, and ICAM-1. J Clin Apher 2002; 17: 38-43.
  • Agishi T, Naganuma S, Nakasato S et al.: Treatment of arteriosclerotic obstructions by LDL adsorption. Angiology 1993; 44: 222-27.[Crossref]
  • Suzuki H, Mutoh E, Kitagawa T et al.: Arteriosclerosis obliterans that was improved by LDL apheresis. Hokkaido Igaku Zasshi 1993; 68: 126-31.
  • Diehm N, Shang A, Silvestro A et al.: Association of cardiovascular risk factors with pattern lower limb atherosclerosis in 2659 patients. Eur J Vasc Endovasc Surg 2006; 31: 59-63.
  • Ito M, Mishima Y: Risk factors, natural history and prognosis of the patients with arteriosclerosis obliterans. Nippon Geka Gakkai Zasshi 1996; 97: 476-80.
  • Meyer WW, Kauffman SL, Hardy-Stashin J: Studies on the human aortic bifurcation. Predilection sites of early lipid deposits in relation to preformed arterial structures. Atherosclrerosis 1980; 37: 389-97.
  • Kroger K, Buss C, Renzing-Kohler K et al.: Segmental manifestation of peripheral atherosclerosis and its association to risk factors. Vasa 2000; 29: 199-203.[PubMed][Crossref]
  • Smith FB, Lee AJ, Fowkes FG et al.: Variation in cardiovascular risk factors by angiographic site of lower limb atherosclerosis. Eur J Vasc Endovasc Surg 1966; 11: 340-46.
  • Wiseman SA, Powell JT, Barber N et al.: Influence of apolipoproteins on the anatomical distribution of arterial disease. Atherosclerosis 1991; 89: 231-37.
  • Mowat BF, Skinner ER, Wilson HM et al.: Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease. Atherosclerosis 1997; 131: 161-66.
  • Jensen SA, Vatten LJ, Nilsen TIL et al.: Serum lipids and anthropometric factors related to the prevalence of intermittent claudication. Eur J Vasc Endovasc Surg 2005; 30: 582-87.[Crossref][PubMed]
  • Kozlovszky B, Mohacsi A, Bajnok L et al.: Clinical and biochemical parameters of patients with vascular stenosis in the lower extremities in the stage of intermittent claudication. Orv Hetil 1995; 136: 817-22.
  • Naruszewicz M, Mirkiewicz E, Kłosiewicz-Latosźek L: Modification of low density lipoproteins from hypertriglyceridic patients by macrophages in vitro the effect of bezafibrate treatment. Atherosclerosis 1989; 79: 261-65.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_v10035-007-0082-y
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.